Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Loading Events

« All Events

OBN BioLearn: ‘Introduction To Drug Development’

February 19 @ 9:00 am

This life science course provides a comprehensive understanding of the journey a new drug takes from initial development through to patient use. It covers everything from technical development and preclinical safety to clinical trials, regulatory approval, and commercialisation. Participants will gain insight into the processes involved in ensuring a drug’s safety, viability, and global accessibility, along with the manufacturing and supply chain considerations for scaling up production.

This course offers an in-depth understanding of the journey a new drug takes from development to patient use, covering key stages including:

  • Technical Development – Creating the drug and medicine.
  • Preclinical Safety – Ensuring safety for human use.
  • Clinical Trials – Evaluating drug viability.

And more!

Who Should Attend?

Ideal for scientific, technical, and service function professionals seeking a deeper understanding of the drug development process, from discovery to patient delivery.

Details

Date:
February 19
Time:
9:00 am
Event Category:
Website:
https://obn.glueup.com/event/obn-biolearn-introduction-to-drug-development-112315/

Organiser

OBN
Go to Top